Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
59M
Number of holders
96
Total 13F shares, excl. options
32.2M
Shares change
-5.5M
Total reported value, excl. options
$329M
Value change
-$56.4M
Put/Call ratio
0.54
Number of buys
46
Number of sells
-45
Price
$10.23

Significant Holders of Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) as of Q1 2023

110 filings reported holding CGEM - Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 32.2M shares of 59M outstanding shares and own 54.58% of the company stock.
Largest 10 shareholders include BIOIMPACT CAPITAL LLC (7.65M shares), CHI Advisors LLC (3.35M shares), BVF INC/IL (3.2M shares), VANGUARD GROUP INC (2.55M shares), BlackRock Inc. (2.26M shares), AMERICAN INTERNATIONAL GROUP, INC. (1.24M shares), Nextech Invest Ltd. (1.22M shares), Boxer Capital, LLC (1.07M shares), FRANKLIN RESOURCES INC (789K shares), and Rubric Capital Management LP (627K shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.